Home Miscellaneous All information about the drug is "carcinogenic" after its discovery

After cancer has been a devastating disease for many years without definitive treatment, it seems to be about to change and revolutionize the medical world after the FDA announced the world's first drug to treat cancer from its source and his control. It.

Vitracafe is the new anti-cancer drug, in the form of adult pills or children's drink, that treats genetic mutations of cancerous tumors, regardless of the type or location of the disease.

According to Sky News, doctors can prescribe this drug to patients in the following cases, if the tumor results from "NTRK" genes are abnormal, if cancer cells spread in the body, or if surgery to eliminate cancer causes complications complex, other treatments are acceptable, or if the cancer does not respond to other treatments and is more widespread If the doctor has prescribed Vitracopy, he must first try to make sure that it is treated properly in small doses before asking it to be used in larger quantities.

Although it is not known if Vitracafe is appropriate and safe for use in children under one month, according to the website "Drags" of Medicine, stating that the doctor must be informed of antecedents patient's medical, especially liver problems, or If the patient or patient intends to have children, the drug will affect the fetus and the doctor will need to be informed if the patient is badfeeding a child .

Depending on the side effects of the medication, you can change the dose, follow your doctor's instructions for taking the capsule or syrup, and ask the doctor to explain. How to calculate the amount of medicine precisely if it is a drink, while if the capsules are swallowed immediately, without crushing or chewing.

The medical site explained that if the patient forgets to take the dose of medicine in time, take it as soon as you remember, provided that the next dose is not after 6 hours, in this case, wait until next dose.

The drug also includes side effects, including nervous system, liver and fatigue problems, as well as fatigue, nausea, dizziness and vomiting, as well as constipation and diarrhea and a decrease in symptoms. reproductive capacity, especially in women.

The Saudi Ministry of Health, through its official account on Twitter, announced that "this drug does not treat cancer completely or completely, but it aims to control its growth and spread for as long as possible and does not replace surgical treatment, Radiation ".

The new treatment has recently been approved by the Food and Drug Administration (FDA) to treat specific cases of cancer with a specific type of rare genetic mutations (TRK gene). This rare mutation is present in certain tumors such as the salivary gland, the thyroid, the lung and the connective tissue. The treatment of cases containing genetic mutations does not tolerate surgery, as well as cases containing genetic mutations and there is no appropriate alternative to treatment or cases developed after the prescribed treatment.

The New England Journal of Medicine reported that the drug had been studied in Phase I and II, including 55 cancer patients with the TRK gene, with a response rate of 13% and a partial response rate of 62%.

"This response did not last long for all patients, as the disease developed in some study participants and continued to respond in 39% of patients after the first year of treatment. , and some patients were operated on after treatment. "

The Russian site Sputnik said that the drug cost up to now more than $ 393,000 a year, against $ 11,000 a month.

News that you can like